The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly;Wptyw przezklinowej resekcji gruczolaka przysadki na gospodarkę węglowodanową i insulinooporność w akromegalii

Neurologia i Neurochirurgia Polska

Volumn 45, Issue 4, 2011, Pages 328-334

  Stelmachowska Banaś, Maria ^a   Zieliński, Grzegorz ^b   Zdunowski, Piotr ^a   Podgórski, Jan ^b   Zgliczyński, Wojciech ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ACROMEGALY; ADULT; AGED; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GROWTH HORMONE SECRETING ADENOMA; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

EID: 80054965568     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.1016/S0028-3843(14)60103-1     Document Type: Article

References (31)

1. Nabarro J.D. Acromegaly. Clin Endorinol 1987; 26: 481-512.
2. Wright A.D., Hill D.M., Lowy C., et al. Mortality in acro - megaly. Q J Med 1970; 39: 1-16.
3. Bengtsson B.A., Edén S., Ernest I., et al. Epidemiology and long term survival in acromegaly. Acta Med Scand 1988; 223: 327-335.
4. Orme S.M., McNally R.J., Cartwright R.A., et al. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 1998; 83: 2730-2734.
5. Dekkers O.M., Biermasz N.R., Pereira A.M., et al. Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 2008; 93: 61-67.
6. Clayton R.N. Cardiovascular function in acromegaly. Endocr Rev 2003; 24: 272-277.
7. Foss M.C., Saad M.J., Paccola G.M., et al. Peripheral glucose metabolism in acromegaly. J Clin Endocrinol Metab 1991; 72: 1048-1053.
8. Hansen I., Tsalikian E., Beaufrere B., et al. Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol 1986; 250: E269-E273.
9. Pietrobelli D.J., Akopian M., Olivieri A.O., et al. Altered cir - cadian blood pressure profile in patients with active acromegaly. Relationship with left ventricular mass and hormonal values. J Hum Hypertens 2001; 15: 601-605.
10. Arosio M., Sartore G., Rossi C.M., et al. LDL physical pro - perties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy. Italian Multicenter Octreotide Study Group. Atherosclerosis 2000; 151: 551-557.
11. Colao A., Baldelli R., Marzullo P., et al. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 2000; 85: 193-199.
12. Kreze A., Kreze-Spirova E., Mikulecky M. Risk factors for glucose intolerance in active acromegaly. Braz J Med Biol Res 2001; 34: 1429-1433.
13. Biering H., Knappe G., Gerl H., et al. Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Austriaca 2000; 27: 27-31.
14. Kasayama S., Otsuki M., Takagi M., et al. Impaired ß-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol 2000; 52: 549-555.
15. Colao A., Ferone D., Marzullo P., et al. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Rev 2004; 25: 102-152.
16. Melmed S., Colao A., Barkan A., et al. Acromegaly Consensus Group. Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 2009; 94: 1509-1517.
17. Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest 2009; 119: 3189-3202.
18. WHO and IDF 2006 Updated guidelines for the definition, diagnosis and classification of diabetes mellitus. http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf.
19. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Katz A., Nambi S.S., Mather K., et al. Quantitative insulin sen - sitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
21. Stelmachowska-Banaś M., Zdunowski P., Zgliczyński W. Abnor - malities in glucose homeostasis in acromegaly. Does the pre - valence of glucose intolerance depend on the level of activity of the disease and the duration of the symptoms? Endokrynol Pol 2009; 60: 20-24.
22. Swearingen B., Biller B.M., Barker F.G., et al. Long-term mor - tality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998; 83: 3419-3426.
23. Holdaway I.M., Rajasoorya R.C., Gamble G.D. Factors in - fluencing mortality in acromegaly. J Clin Endocrinol Metab 2004; 89: 667-674.
24. Adler A.I., Neil H.A., Manley S.E., et al. Hyperglycemia and hyper insulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47). Am Heart J 1999; 138: S353-S359.
25. de Vegt F., Dekker J.M., Stehouwer C.D., et al. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care 2000; 23: 40-44.
26. Jaffrain-Rea M.L., Minniti G., Moroni C., et al. Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. Eur J Endocrinol 2003; 148: 193-201.
27. Colao A., Auriemma R.S., Galdiero M., et al. Impact of soma - tostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. J Clin Endocrinol Metab 2009; 94: 528-537.
28. Ronchi C.L., Varca V., Beck-Peccoz P., et al. Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors. J Clin Endocrinol Metab 2006; 91: 121-128.
29. Wasada T., Aoki K., Sato A., et al. Assessment of insulin resi - stance in acromegaly associated with diabetes mellitus before and after transsphenoidal adenomectomy. Endocr J 1997; 44: 617-620.
30. IDF 2006, International Diabetes Atlas. http://www.diabetes atlas.org.
31. Damjanovic S.S., Neskovic A.N., Petakov M.S., et al. Clinical indicators of biochemical remission in acromegaly: does in - complete disease control always mean therapeutic failure? Clin Endocrinol 2005; 62: 410-417.